AXSOME THERAPEUTICS, INC. (AXSM) /
The revenue of AXSOME THERAPEUTICS, INC. over the past 10 years
Chart AXSOME THERAPEUTICS, INC.: revenue, fiscal 2016–2025 Open the chart →AXSOME THERAPEUTICS, INC. reported revenue of $638.5M in fiscal 2025, the latest fiscal year on file. In fiscal 2022 it was $50.04M — up 1176% over 3 years. Year over year, revenue rose every year. The largest one-year move was in fiscal 2023: up 441%, from $50.04M to $270.6M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $638.5M |
| 2024ended Dec 31, 2024 | $385.69M |
| 2023ended Dec 31, 2023 | $270.6M |
| 2022ended Dec 31, 2022 | $50.04M |
| 2021ended Dec 31, 2021 | — |
| 2020ended Dec 31, 2020 | — |
| 2019ended Dec 31, 2019 | — |
| 2018ended Dec 31, 2018 | — |
| 2017ended Dec 31, 2017 | — |
| 2016ended Dec 31, 2016 | — |
Fiscal years as AXSOME THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AXSOME THERAPEUTICS, INC.
- The profitability of AXSOME THERAPEUTICS, INC.
- The cash flow of AXSOME THERAPEUTICS, INC.
- The debt of AXSOME THERAPEUTICS, INC.
- All of AXSOME THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- AGCOAGCO CORP /DE
- APPFAppFolio, Inc.
- ALKSAlkermes plc.
- URBNUrban Outfitters, Inc.
- SSDSimpson Manufacturing Co., Inc.
Not investment advice. This page shows what AXSOME THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.